August 11, 2010 – Based on its recent analysis of the computed tomography (CT) market, Frost & Sullivan recognizes Siemens Healthcare with the 2010 North American Frost & Sullivan Award for Technology Leadership of the Year.

August 9, 2010 - Health care professionals will attend a conference devoted to the fundamentals of establishing and developing a cooling program and features Minneapolis physicians and other national experts, Miracle on Ice: Therapeutic Hypothermia for Cardiac Arrest Patients conference will take place September 9 to 10, in Minneapolis, Minn.

August 9, 2010 – Enrollment was recently completed in a clinical trial of Medtronic’s Complete SE (self-expanding) vascular stent for the treatment of atherosclerosis in the superficial femoral artery (SFA), including the proximal popliteal artery (PPA).

August 9, 2010 – A merger is being finalized between Medtronic and cardiac surgery device maker ATS Medical. The company develops and manufactures products and services for the treatment of structural heart disease and the ablation of cardiac arrhythmias. ATS Medical expects the closing of the merger will take place on or about Aug. 12.

August 4, 2010 — When Beaumont Hospital physicians recently held a heart screening for high school students, they found some surprising results. Of the 402 students screened, 34 students were advised to continue with sports and follow-up with their personal physicians and an additional five students were instructed to stop exercise until fully evaluated.

August 3, 2010 — Patient enrollment began in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Boston Scientific Synergy Coronary Stent (previously referred to as the Evolution stent). It uses a bioabsorbable polymer and everolimus drug formulation to create a thin, uniform coating confined to the outer surface of the stent.

August 3, 2010 — St. Joseph’s Regional Medical Center (SJRMC) in Paterson, N.J., received the Chain of Survival Award from the Sudden Cardiac Arrest Association and accolades from New Jersey Gov. Chris Christie for its trendsetting work in using prehospital therapeutic cooling of cardiac arrest patients.